The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I’m also sorry for my part but when people post insults whilst proclaiming to be righteous and then follow them with half truths I will be here to post a response and will continue to do so.
Looks like the only spoilng of today is the arguing between Doc and Tommy
Thanks for all the work!
Hey Doc83,
Thanks for your feedback as well as the others that attended.
Was there a rep from Polygon? If so, did you get a chance to chat!!!
Hi JoeyDiamond - I didn’t see any recording equipment of any kind. But I may have missed it. My impression was that there will be nothing like that provided.
I’m here to have a civilised conversation and your portrayal of my posting is completely inaccurate but probably meant to be.
But I will continue to follow the inaccuracies posted by know contributors and correct them of that you can be assured
Look forward to reading it. Will there be a video or audio recording of the AGM at a later date?
Tommy - You have a history of shrill and *****y insults. This is a pleasant forum for people interested in discussing the pros and cons of SNG. People can have civilized differences of opinion on a topic.
Massive thank you wigster77 and doc83. Very good of you to spend the time to write up the conversations of today as you really didn’t have to go out your way for the benefit of this board.
The only one who throws cheap insults calling people plebs etc is you and as for claiming rights. I’m not claiming anything. I’m just stopping you telling your usual lies dressed up as half truths
It’s also worth pointing out that clinical treatments guidelines for Covid patients who are not responding to SOC or at high risk of progression to severe disease still include offering Remdesivir and Marbs. These are not cheap options
Bear with us team. I've typed up the bit before the Q&A and even that runs to 80 lines in word...Doc83 will be checking this over later this evening
I'm just typing up the Q&A part now. It's been a long day and this is taking ages as I'm trying to be as comprehensive as possible - hopefully you'll find it of use and worth the wait.
People are surviving with SOC but many suffering long health consequences after Covid-19 and a third of our patients in our trial showed a 70% improvement over SOC. our drug was never the answer for every Covid-19 patient but those who don’t recover and go on to have severe breathing issues SOC is not the answer
Tommy
Of course it would be cheap to save a life, as I too stated.
Current SOC has been proven to save lives for a lot less than our drug costs.
Of course I hope I am very wrong and we suddenly get included on a platform trial, preferably in the US and that A2 data arrives and is excellent.
I’m just looking at the facts thus far, not hearsay or speculation.
Yes, I will be watching for the synopsis from Doc and wigster, etc.
ATB
Sadly Docdaneeka spreads half truths with mistruths, jibes and insults in what I can only assume is an attempt to scare genuine shareholders on the future prospects for Synairgen.
I would treat anything he says with a large amount of scepticism, he’s not in my view a genuine investor
From someone who attended
Doc83
Posts: 1,381
Price: 29.50
No Opinion
RE: AGM questionsToday 16:36
Tommy - I think that’s a very fair assessment. It went on until around 11.15am, with most of that for Q&A for those in the room…. Got to give them full credit for that. They were peppered non stop with questions and I thought answered most of them well. A few responses I particularly liked, and I tend to agree that Synairgen’s future is far from done.
Kevin
If you can get someone out of a hospital bed then it’s absolutely worth it to treat them with our drug. Hospitalisation is a very expensive care package and in the US an astronomical care package
There is absolutely new things from today. Don’t believe a word DocDaneeka posts.
Today was a positive update for shareholders
Kevin
Why not wait until Doc83 and Wigster post their review of the answers to
questions we all contibuted to for the AGM today ?
I am sure you have worked out that they are both cautious and well researched investors in SNG.
You may be pleasantly surprised !
*every year during Winter
SSH responded strongly to the question of whether the product cost of SNG001 would be good value to health services.
He pointed out that every year hospitals are brought to their knees purely by respiratory viruses.
He also pointed out that the world is now due a big flu wave since the populations flu immunity has been dramatically reduced by masks and social distancing.
Let’s face facts.
Who is going to use our product at £2k cost, unless it will save a life?
Any takers; I doubt it.
It is not cost friendly to treat flu or the common cold.
Usual response: we are having loads of discussion with potential ventures/trials.
What else can the BOD say?
We may find a market eventually for a certain sub group, but it’s way off at the moment.
No A2 data which I’m pretty sure is average, otherwise it would already be being investigated to prepare for the next variants or pandemic.
Let’s wait for another trial and then see what’s what.
GLA
Childish digs at the Reddit board. People on that board were actively interested in any question people on LSE wanted asking at the AGM.
Some of you need to grow up
The Pal, Doc and Mani
You're more than welcome
ATB
Thanks guys for your feed back it looks good might end up blue day as well can't wait for the updates later